Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

W. Zeijlemaker; A. Kelder; Y. J. M. Oussoren-Brockhoff; W.  Scholten; A. N. Snel; D. Veldhuizen; J. Cloos; G. J. Ossenkoppele; G. J. Schuurhuis

doi:10.1038/leu.2015.255

Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

W. Zeijlemaker, A. Kelder, Y. J. M. Oussoren-Brockhoff, W. Scholten, A. N. Snel, D. Veldhuizen, J. Cloos, G. J. Ossenkoppele, G. J. Schuurhuis

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	708-715
Journal	Leukemia
Volume	30
Issue number	3
DOIs	https://doi.org/10.1038/leu.2015.255
Publication status	Published - Mar 2016

Access to Document

10.1038/leu.2015.255

Cite this

Zeijlemaker, W., Kelder, A., Oussoren-Brockhoff, Y. J. M., Scholten, W., Snel, A. N., Veldhuizen, D., Cloos, J., Ossenkoppele, G. J., & Schuurhuis, G. J. (2016). Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia. Leukemia, 30(3), 708-715. https://doi.org/10.1038/leu.2015.255

@article{998d547f01e347adb132d414fcfc451f,

title = "Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia",

author = "W. Zeijlemaker and A. Kelder and Oussoren-Brockhoff, {Y. J. M.} and W. Scholten and Snel, {A. N.} and D. Veldhuizen and J. Cloos and Ossenkoppele, {G. J.} and Schuurhuis, {G. J.}",

year = "2016",

month = mar,

doi = "10.1038/leu.2015.255",

language = "English",

volume = "30",

pages = "708--715",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "3",

}

Zeijlemaker, W, Kelder, A, Oussoren-Brockhoff, YJM, Scholten, W, Snel, AN, Veldhuizen, D, Cloos, J , Ossenkoppele, GJ & Schuurhuis, GJ 2016, 'Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia', Leukemia, vol. 30, no. 3, pp. 708-715. https://doi.org/10.1038/leu.2015.255

Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia. / Zeijlemaker, W.; Kelder, A.; Oussoren-Brockhoff, Y. J. M. et al.

In: Leukemia, Vol. 30, No. 3, 03.2016, p. 708-715.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

AU - Zeijlemaker, W.

AU - Kelder, A.

AU - Oussoren-Brockhoff, Y. J. M.

AU - Scholten, W.

AU - Snel, A. N.

AU - Veldhuizen, D.

AU - Cloos, J.

AU - Ossenkoppele, G. J.

AU - Schuurhuis, G. J.

PY - 2016/3

Y1 - 2016/3

U2 - 10.1038/leu.2015.255

DO - 10.1038/leu.2015.255

M3 - Article

C2 - 26373238

VL - 30

SP - 708

EP - 715

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 3

ER -